Table 2.

Performance of PRM-based urinary marker panels with/without urinary PSA in the independent cohort.

Panel	GG1 versus GG4	GG1 versus GG2	GG1 versus GG3	GG1 versus GG2 and above	GG1 versus GG3 and above
	AUC (95% CI)	AUC (95% CI)	AUC (95% CI)	AUC (95% CI)	AUC (95% CI)
ACPP	0.71 (0.54, 0.87)	0.61 (0.45, 0.78)	0.66 (0.49, 0.83)	0.66 (0.50, 0.81)	0.68 (0.53, 0.84)
ACPP + CLU	0.65 (0.48, 0.82)	0.55 (0.38, 0.71)	0.68 (0.50, 0.85)	0.62 (0.47, 0.78)	0.68 (0.52, 0.84)
ACPP + CLU + Urinary PSA	0.65 (0.48, 0.82)	0.54 (0.38, 0.70)	0.71 (0.54, 0.88)	0.62 (0.48, 0.76)	0.68 (0.53, 0.84)